A press release hits. Before you've finished reading the headline, FirstPrint has:
• the float and dilution risk
• whether the company can sell shares today
• a bullish/bearish read on what it means
Every filing. Every PR. Live.
$NXAT was set for a Nasdaq suspension at today's open. FirstPrint flagged it at 4:05 AM, before the 5:54 AM spike to $2.19, +879.0% from a $0.2237 close.
Alert: appeal likely filed, hearing pending. 1-for-8 vote Dec 28. Can it sell? No.
Not investment advice. https://t.co/EbokUEPHKT
1/ FirstPrint weekly update 🧵
We shipped a lot this week, and this weekend we're auditing every company page for accuracy.
2/ New:
• Missed-delisting alerts: if a stock is still trading after its scheduled suspension, you see it in the News Stream at 4:05 AM ET, before the open $NXAT
• Foreign 6-K filings now get real headlines, split votes and delisting notices
3/ Company pages:
• Dividend line for payers
• Dates on every row of "Where new shares can come from"
• A "likely already sold" note on older resale filings
• Delisting/BK list rebuilt
4/ Also:
• Gamma map in Options Flow
• Headlines-only rows in the News Stream
• Faster iPhone search and taps
5/ Accuracy: this weekend we re-check share counts after reverse splits, newer proxy share counts and convertible notes in overhead across every company, and re-read warrants from the filings.
If you see a number that looks off, reply or DM us. We fix it fast.
https://t.co/1KSl6dWpi7
-Robinhood took away the sell button when shit hit the fan.
-Schwab / Webull / Etrade force close accounts for no reason.
You want an edge? Open an @Aries account and sign up for @firstprinthq. The fastest broker paired with the fastest data service.
And fyi- I'm not a paid promoter, they're just the best.
$VIVS hit $0.232 today, +93.3% from Wednesday’s $0.12 close.
At 8:05 AM ET, VivoSim Labs announced a seven-figure agreement with a top-10 global pharmaceutical company and said it expects to exceed its 500%+ revenue growth guidance for fiscal 2027.
It landed in the FirstPrint News Stream as it posted, with the AI read one hover away.
What FirstPrint showed:
AI read: moderate bullish. NAMkind liver and intestinal toxicology testing, revenue expected in fiscal Q3 and Q4; the dollar amount isn’t disclosed
Can it sell new shares today? Yes: about $1.68M through its ATM (baby-shelf cap of 1/3 of a $5.04M public float, nothing sold in the last 12 months; about $3.1M left on the ATM per the 10-Q)
1.56M pre-funded warrant shares were still outstanding at Sep 30, at $0.001
Cash: $8.56M at Sep 30, nothing raised since, about 7 months of runway
Every release and filing, read the moment it posts. Try it free → https://t.co/EbokUEPHKT
Not investment advice.
Every big options print, as it hits.
FirstPrint Options Flow:
Surge alerts when big money piles into a contract
Live tape of sweeps and blocks, with your watchlist starred
Filter by premium, % at the ask, calls/puts, sweeps, and index on/off
Watch any contract and follow it
Net flow and market tide, plus past days
Try it → https://t.co/EbokUEPHKT
Options data via Unusual Whales. Not investment advice.
Ask FirstPrint anything about a stock. Can $CLRO sell shares today? How long does the cash last? Who filed a 13D? Answers come from the SEC filings, every number cited. Then turn any answer into an alert.
Try it free → https://t.co/P3FaSRNJ0T
Not investment advice.
Ask FirstPrint anything about a stock. Can $CLRO sell shares today? How long does the cash last? Who filed a 13D? Answers come from the SEC filings, every number cited. Then turn any answer into an alert.
Try it free → https://t.co/P3FaSRNJ0T
Not investment advice.
Everything about a stock's dilution, on one page. Here's $HIHO:
- Five risk ratings, each with the reason
- Can it sell new shares today? Answered from its filings
- Float, cash and runway, every number linked to the SEC filing it came from
- David Lazar's preferred-share control deal: 87.9M shares if shareholders approve
- Every warrant, convert and shelf, plus who holds the stock (13D and 13F)
Read from SEC filings the moment they post. Try it free → https://t.co/EbokUEPHKT
Not investment advice.
$CLRO hit $8.65 today, +83% from Tuesday's $4.72 close.
Last night at 9:49 PM ET, ClearOne's majority holder filed a 13D/A. It landed in the FirstPrint News Stream as it posted, with the AI read one hover away:
- Who: First Finance Ltd. (controlled by Andrew Hromyk)
- Stake: 2,141,161 shares, 58.3% of the 3,675,411 outstanding
- New shares: 499,999 at $4.00 (188,885 for $755,540 cash, 311,114 to settle $1.24M of loans)
- Item 4 purpose: build stockholders' equity to regain Nasdaq listing compliance and complete the Cortigent merger (12.5M shares to Vivani). A control holder backing the deal, not an activist campaign.
- Same-day 8-K: 999,999 new shares at $4.00 in all ($2.76M cash + $1.24M debt), pro forma equity $3.28M vs. the $2.5M Nasdaq minimum, filed for its Nov 17 Nasdaq hearing (no panel decision filed as of this morning).
- Can ClearOne sell new shares today? No effective shelf, ATM or equity line.
Every SEC filing, read the moment it posts. Try it free → https://t.co/EbokUEQfAr
Not investment advice.
$HIHO hit $1.97 today, +60% from Tuesday’s $1.23 close.
What FirstPrint showed on the HIHO page:
6:00 AM, PR Newswire: Q2 FY2027 revenue up 107% to $2.44M, back to operating profit
Nov 16: a US$0.43228/share special dividend (US$2.0M total, payable Nov 30, holders of record Nov 27)
Can it sell new shares today? No: no effective shelf, ATM or equity line
David Lazar’s Series AAA preferred: 87M shares, not registered and not convertible without a shareholder vote
Every release and filing, read the moment it posts. Try it free → https://t.co/EbokUEPHKT
Not investment advice.
Tuesday's biggest runners, and what FirstPrint showed first.
$SLS: Phase 3 hit at 7:00 AM. The 8-K was in FirstPrint at 7:14 AM with the read on the row. High $34.00 at 8:33 AM.
$FRTT: record revenue, +49%. Release 7:32 AM, 6-K 7:58 AM. High $0.75. SMTK: merger-partner news at 7:00 AM, +39% in the first minute.
Every catalyst. The second it hits. Try it free → https://t.co/EbokUEQfAr
Not investment advice.
$FRTT up as much as 97% today.
7:58 AM: record nine-month revenue (+49%), gross profit up 202%. FirstPrint had the filing, the AI read and the full dilution picture before the open:
• Can they sell shares today? No shelf, ATM or equity line
• $20M convertible note facility signed Nov 11, not closed yet
• Parent Nexera owns about 70%
Know what's in every filing, and press release instantly.
14-day free trial at https://t.co/EbokUEQfAr
Not investment advice.
FirstPrint is now in your pocket 📱
Every SEC filing and press release, read by AI the moment it drops. Dilution risk, cash runway, whether a company can sell shares today, and Top Movers with the reason behind every move.
Set an alert and your phone buzzes the second a company files.
Try it free → https://t.co/EbokUEPHKT
Trading small caps? Get a free month of FirstPrint 🎁
Every SEC filing read the moment it posts, dilution risk on every ticker, real-time news, scanners & AI research. One screen.
Sign up with my link: start a 14-day free trial, and your first paid month earns you a free month 👇
https://t.co/V5P6jQfVJ8
https://t.co/EbokUEPHKT
$VIVK ran +89.7% to $0.3984 today.
The catalyst: a 3:10 PM late-filing notice guiding to sharply higher revenue. No press release.
FirstPrint caught the filing, read it, and showed the full dilution profile in one hover.
https://t.co/P3FaSROgQr
https://t.co/0MiCORWQu0 had maintenance issues this afternoon and EDGAR's filings feed slowed to a crawl, so some filings on FirstPrint arrived late.
What we shipped today so it doesn't happen again: • A second, faster SEC source running in parallel • A watchdog that auto-fails over if we fall 2+ min behind • Direct checks on movers & watchlist tickers every few seconds
Before you chase a runner, ask one question: can they sell shares?
$HIHO: No. Nothing registered, Lazar preferred not convertible into common yet. It ran +78% on a special dividend.
FirstPrint answers it in seconds